{
    "clinical_study": {
        "@rank": "25145", 
        "arm_group": {
            "arm_group_label": "Study group", 
            "description": "All patients who underwent stem cell mobilization after chemotherapy and G-CSF at our institution between 2002 and 2013"
        }, 
        "brief_summary": {
            "textblock": "Stem cell mobilization procedures after chemotherapy and G-CSf performed at our Institution\n      between 2002 and 2013 were reviewed in order to define prognostic factors for optimal\n      harvest"
        }, 
        "brief_title": "Peripheral Blood CD34-positive Cells Enumeration as Predictor of Stem Cell Harvest", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Blood Stem Cell Harvest Failure", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Mobilization with chemotherapy and G-CSF\n\n          -  Years 2002-2013\n\n        Exclusion Criteria:\n\n          -  mobilization with G-CSF alone\n\n          -  mobilization with plerixafor"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "16 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients who underwent mobilization"
            }
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02023814", 
            "org_study_id": "Emato_aferesi"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 24, 2013", 
        "number_of_groups": "1", 
        "official_title": "Peripheral Blood CD34+ Cells Count as Predictor of Stem Cell Harvest After Chemotherapy and G-CSF. A Single Center Experience", 
        "overall_official": {
            "affiliation": "Ospedale S Croce e Carle", 
            "last_name": "Roberto Sorasio", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Patients not able to harvest at least 2x10e6 CD34+/Kg in the specified time frame are considered failures", 
            "measure": "Blood Stem cell harvest failure rate", 
            "safety_issue": "No", 
            "time_frame": "7 days from hematological recovery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02023814"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ospedale Santa Croce-Carle Cuneo", 
            "investigator_full_name": "Roberto Sorasio", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Ospedale Santa Croce-Carle Cuneo", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ospedale Santa Croce-Carle Cuneo", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2002", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}